UBC Medical Indonesia Tbk. vs Trimuda Nuansa Citra Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Trimuda Nuansa Citra Tbk. trades at Rp135 (market cap 56.5B, 639.4K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 10.2× Trimuda Nuansa Citra Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 639.4K). Which is the better fit depends on your goals.
| LABS | TNCA | |
|---|---|---|
Market Cap | 576.7B | 56.5B |
Volume | 3.48M | 639.4K |
Lot | 34.82K | 6.39K |
Turnover | 522.79M | 86.61M |
Average Price | 150.13 | 135.45 |
Value | 522.79M | 86.61M |
Indicative Equilibrium Price | 148 | 135 |
Indicative Equilibrium Volume | 350 | 341 |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT Trimuda Nuansa Citra Tbk(the Company) was established in Indonesia in accordance with Deed of Establishment of Limited Liability Company Company No. 21 dated May 4, 1995 made before H. Asmawel Amin, S.H., Notary in Jakarta.
Read more on TNCA →